Dr. Neil Bodie founded Paradigm Immunotherapeutics Inc. in 2014, where he is currently president and CEO. Paradigm is developing disruptive technology for highly infectious agents, such as Ebola and novel treatments for immune mediated diseases. Dr. Bodie has been researching the causes and treatments for autoimmune diseases and viral induced immune mediated diseases since 1997, and is also the lead inventor of seven issued U.S. patents and multiple U.S. and World/PCT patent applications.